Today's Rundown Eli Lilly to shutter neuroscience R&D center next year Reata shocks analysts with pivotal win in Friedreich's ataxia Woodford cut down as fund chopped and burned [Sponsored] A New Starting Point for Patient Support: Technology-Driven Hub Services Boehringer's VC wing backs anti-cancer virus startup Aeglea, long-term Eli Lilly veteran nabs CMO job at Checkmate Marrying CRISPR with immuno-oncology to defeat remote tumors Featured Story | | | Tuesday, October 15, 2019 Eli Lilly is closing down its U.K.-based Erl Wood neuroscience in Surrey, leading to cuts and relocations. |
|
|---|
|
Top Stories Tuesday, October 15, 2019 A phase 2 trial of Reata Pharmaceuticals’ omaveloxolone in patients with Friedreich’s ataxia has met its primary endpoint. The positive result, which surprised analysts, tees Reata up to file for FDA approval of the activator of Nrf2 and expand development to other neurodegenerative diseases. Tuesday, October 15, 2019 After being hailed as a near mystic when it came to stock picks, Britain’s once great oak has been cut down to a sapling as Neil Woodford gets the ax and his eponymous fund is cut up. Monday, October 14, 2019 Flipping the script for specialty medications – improved patient access and time-to-therapy with a new tech-enabled platform from CoverMyMeds and RxCrossroads by McKesson. Tuesday, October 15, 2019 Abalos Therapeutics has raised €12 million ($13 million) to discover and develop cancer drugs based on an arenavirus strain. The series A round sets Abalos up to generate anti-tumoral virus strains and take them toward testing in humans. Tuesday, October 15, 2019 Next-gen cancer biotech Checkmate Pharmaceuticals has grabbed a new chief medical officer after a year of C-suite shuffles. Monday, October 14, 2019 Yale scientists have combined the gene-editing system CRISPR with a type of gene therapy designed to help the immune system find tough-to-spot tumor cells. The technology showed promise in mouse models of triple-negative breast cancer, melanoma and pancreatic cancer. | | Experts in our field; with 20+ years of experience in Viral Vector and plasmid DNA (R&D, High Quality and GMP) manufacture for pre-clinical, clinical and commercial supply. Take a virtual tour of our facilities and find out more about our most recent expansion project. |
Resources Sponsored by: Outer Edge Technology Companies that don’t have a cloud strategy are at a competitive disadvantage. Why? The cloud has a measurable impact on business. Sponsored by: Medidata Simplified filing, improved oversight, audit readiness: is your eTMF system delivering best-in-class benefits? Sponsored by: Colorcon® Learn about how you better manage product authentication and battle drug counterfeiting with innovative solutions. Sponsored by: Cortellis, a Clarivate Analytics Solution Download this report for full details of Life sciences M&As in the second quarter of 2019 with notes and trends. Sponsored by: Elligo Health Research Find out how it leverages real-world data and novel IntElligo Research Stack™ technology to help researchers battle rising costs, cumbersome processes, and stagnant participation — bridging the gap between research and care. Sponsored by: InformedDNA Download this complimentary guide paper that explores key strategies for a successful genetics-informed clinical trial. Sponsored by: Life Image The time has finally come when medical imaging can be effectively utilized into the RWE process. Read the whitepaper on the best practices for incorporating Real World Imaging.™ Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BioAnalytix, Inc. Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: ON24 Compare digital program performance and audience engagement among your life sciences peers. Sponsored by: Decision Resources Group Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem. Sponsored by: Reprints Desk, Inc. Slashing your R&D costs is easier than you think. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Countdown to Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register Now at www.drugstomarket.com/drugbootcamp and start Pre-Boot Camp Preparation | 